naloxonazine and naltrexone

naloxonazine has been researched along with naltrexone in 96 studies

Research

Studies (96)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (4.17)	18.7374
1990's	46 (47.92)	18.2507
2000's	32 (33.33)	29.6817
2010's	14 (14.58)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bell, GI; Chen, Y; Kong, H; Raynor, K; Reisine, T; Yasuda, K; Yu, L	1
Briddon, SJ; Canals, M; Graham, B; Kellam, B; Scammells, PJ; Schembri, LS; Stoddart, LA	1
Larson, AA; Mousseau, DD; Sun, X	1
Jang, Y; Yoburn, BC	1
Baumann, MH; Rabii, J	1
Pasternak, GW; Paul, D; Pick, CG	1
Goodman, RR; Hahn, EF; Nishimura, S; Pasternak, GW	1
Heyman, JS; Jiang, Q; Mosberg, HI; Porreca, F; Rothman, RB	1
Gmerek, DE; Woods, JH	1
Carroll-Buatti, M; Hahn, EF; Pasternak, GW	1
Bodnar, RJ; Cole, JL; Kirkham, TC; Leventhal, L	1
Bodnar, RJ; Bowen, WD; Cole, JL; Leventhal, L; Pasternak, GW	1
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Ohsawa, M; Saitoh, A; Suzuki, T	1
Bodnar, RJ; Glass, MJ; Koch, JE	1
Kromer, W	1
Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Suzuki, T	1
Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Ohsawa, M	2
Elliott, J; Lambert, DG; Smart, D; Traynor, JR	2
Bodnar, RJ; Glass, MJ; Hahn, B; Joseph, A	1
Broccardo, M; Improta, G	1
Búzás, B; Cox, BM; Izenwasser, S	1
Kwok, YN; McIntosh, C; Yago, V	1
Hitosugi, H; Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H	1
Eisenberg, RM	2
Randich, A; Robertson, JD; Willingham, T	1
Cheng, PY; Decena, J; McCabe, S; Soong, Y; Szeto, HH; Wu, D	1
Bodnar, RJ; Koch, JE	1
Nejat, RJ; Pasternak, GW; Pick, CG	1
Henriksen, SJ; Koob, GF; Mattox, A; Negus, SS; Pasternak, GW; Portoghese, PS; Takemori, AE; Weinger, MB	1
Plotsky, PM; Rivest, S; Rivier, C	1
Cheng, PY; Decena, JA; McCabe, S; Soong, Y; Szeto, HH; Wu, D	1
Beczkowska, IW; Bodnar, RJ; Bostock, ME; Koch, JE; Leibowitz, SF	1
Koob, GF; Negus, SS; Pasternak, GW; Weinger, MB	1
Misawa, M; Mori, T; Nagase, H; Suzuki, T; Tsuji, M	1
Negri, L; Noviello, L; Noviello, V	1
Honkanen, A; Hyytiä, P; Korpi, ER; Sarviharju, M; Vilamo, L; Wegelius, K	1
Bodnar, RJ; Cole, JL; Leventhal, L	1
Ahtee, L; Piepponen, TP	1
Bodnar, RJ; Leventhal, L	1
Kamei, J; Nagase, H; Sodeyama, M; Suzuki, T; Tsuda, M	1
Ahtee, L; Katajamäki, J; Kivastik, T; Piepponen, TP; Zharkovsky, A	1
Lysle, DT; Perez, L	1
Aasmundstad, TA; Alkana, RL; Grung, M; Handal, M; Mørland, J; Skurtveit, S	1
Aimi, N; Matsumoto, K; Sakai, S; Takayama, H; Thongpradichote, S; Tohda, M; Watanabe, H	1
Fujimoto, JM; Gorny, JM; Rady, JJ	1
Arcaya, JL; Cano, G; Gómez, G; Maixner, W; Suárez-Roca, H	1
Fujimura, T; Kastin, AJ; Katsuyama, S; Murayama, K; Sakurada, S; Sakurada, T; Ueda, H; Yuki, M; Zadina, JE	1
Fujii, T; Goto, T; Motoyama, Y; Ochi, T	1
Kamei, J; Nagase, H; Ohsawa, M; Zushida, K	1
Esashi, A; Kisara, K; Nakagawasai, O; Niijima, F; Sakurada, S; Tadano, T; Takahashi, N; Tan-No, K; Yonezawa, A	1
Hayashi, T; Kisara, K; Kutsuwa, M; Sakurada, C; Sakurada, S; Sakurada, T; Sato, T; Takeda, S; Tan-No, K; Yuki, M	1
Baumer, F; Bodnar, RJ; Pasternak, GW; Rossi, GC; Stein, JA; Znamensky, V	1
Arakawa, K; Saito, N; Sasaki, T; Shimada, K	1
Hirohashi, M; Kitano, Y; Komiyama, C; Makino, M; Takasuna, K	1
Akil, H; Bonner, G; Meng, F	1
Fujimura, T; Hayashi, T; Kastin, AJ; Murayama, K; Sakurada, C; Sakurada, S; Sakurada, T; Takeshita, M; Yonezawa, A; Yuhki, M; Zadina, JE	1
Fujimura, T; Hayashi, T; Kastin, AJ; Murayama, K; Narita, M; Orito, T; Sakurada, C; Sakurada, S; Sakurada, T; Suzuki, T; Tan-no, K; Tseng, LF; Yuhki, M; Zadina, JE	1
Katoh, T; Mamiya, T; Ukai, M	1
Fujimura, T; Hayashi, T; Kastin, AJ; Murayama, K; Sakurada, C; Sakurada, S; Sakurada, T; Sato, T; Takeshita, M; Yonezawa, A; Yuhki, M; Zadina, JE	1
Imai, S; Itou, Y; Narita, M; Suzuki, T; Yajima, Y	1
Ciccocioppo, R; Martin-Fardon, R; Weiss, F	1
Bardo, MT; Gehrke, BJ; Rauhut, AS; Shortridge, BE	1
Qian, X; Soong, Y; Szeto, HH; Wu, D; Zhao, GM	1
Kamei, J; Morita, K; Nagase, H; Saitoh, A	1
Calvo, F; Carvalho, AD; Castellan-Baldan, L; Coimbra, NC; da Silva, LA; de Oliveira, R; Elias-Filho, DH; Felippotti, TT; Motta, V; Osaki, MY; Paschoalin-Maurin, T; Ubiali, WA	1
Laurito, CE; Lu, Y; Sweitzer, SM; Yeomans, DC	1
Chen, CM; Huang, EY; Tao, PL	1
Fujimura, T; Ito, K; Kawamura, S; Mizoguchi, H; Murayama, K; Nakayama, D; Sakurada, C; Sakurada, S; Sakurada, T; Sato, T; Watanabe, C; Watanabe, H	1
Ambo, A; Bryant, SD; Fujita, Y; Jinsmaa, Y; Lazarus, LH; Li, T; Miyazaki, A; Okada, Y; Sasaki, Y; Shiotani, K; Tsuda, Y	1
Coimbra, NC; Freitas, RL; Kishi, R; Morato, S; Rebouças, EC; Savoldi, M; Segato, EN	1
Aragon, CM; Pastor, R	1
Koseki, M; Matsumura, E; Sakaguchi, M; Wakamatsu, M	1
Bagosi, Z; Bujdosó, E; Jászberényi, M; Szabó, G; Telegdy, G	1
Fushiki, T; Inoue, K; Matsumura, S; Mizushige, T; Tsuzuki, S; Yoneda, T	1
Kamei, J; Nozaki, C	1
Chen, Q; Dong, L; Fu, CY; Ni, JM; Wang, R; Zhao, YL	1
Komatsu, T; Mizoguchi, H; Morimoto, M; Sakurada, S; Sakurada, T; Sato, T; Sawai, T; Watanabe, C; Watanabe, H; Yonezawa, A	1
Bagosi, Z; Jászberényi, M; Telegdy, G	1
Achat-Mendes, C; Platt, DM; Rowlett, JK; Spealman, RD; Valdez, GR	1
Morato, GS; Varaschin, RK	1
Cooper, PD; Cowlings, A; Dennis, SR; Donnelly, C; Woodman, JD	1
Baiula, M; Bedini, A; De Marco, R; Gentilucci, L; Spampinato, S; Tolomelli, A	1
Acquas, E; Fois, GR; Muggironi, G; Peana, AT; Vinci, S; Zinellu, M	1
Goyal, R; Kumar, K; Mohan, A; Mudgal, A; Pasha, S	1
Arulselvan, P; Fakurazi, S; Hairuszah, I; Hidayat, MT; Moklas, MAM; Shamima, AR	1
Bach-Rojecky, L; Drinovac, V; Lacković, Z; Matak, I	1
Dobek, E; Górski, K; Misztal, T; Romanowicz, K	1
Kon-No, T; Mizoguchi, H; Sakurada, S; Sakurada, T; Sato, T; Watanabe, C; Watanabe, H; Yonezawa, A	1
Adachi, S; Fushiki, T; Inoue, K; Matsumura, S; Okafuji, Y; Okahashi, T; Sakamoto, K; Tsuzuki, S	1
Aranda-Fernández, PE; Chotro, MG; Gaztañaga, M	1
Can, ÖD; Kasap, M	1
da Luz, SC; Nogueira, CW; Pesarico, AP; Rosa, SG; Tagliapietra, CF	1
Almada, RC; Calvo, F; Coimbra, NC; da Silva Soares, R; da Silva, JA; de Paiva, YB; Medeiros, P; Roncon, CM	1

Other Studies

96 other study(ies) available for naloxonazine and naltrexone

Article	Year
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Molecular pharmacology, 1994, Volume: 45, Issue:2 Topics: Analgesics; Animals; Binding Sites; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; Ligands; PC12 Cells; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Software	1994
Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting the μ-Opioid Receptor. Journal of medicinal chemistry, 2015, Dec-24, Volume: 58, Issue:24 Topics: Animals; Binding, Competitive; Buprenorphine; CHO Cells; Cricetulus; Fluorescent Dyes; HEK293 Cells; Humans; Ligands; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Radioligand Assay; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship	2015
Identification of a novel receptor mediating substance P-induced behavior in the mouse. European journal of pharmacology, 1992, Jul-07, Volume: 217, Issue:2-3 Topics: Analysis of Variance; Animals; Behavior, Animal; Binding Sites; Indoles; Injections, Spinal; Male; Mice; Morphinans; Naloxone; Naltrexone; Peptide Fragments; Substance P	1992
Evaluation of receptor mechanism mediating fentanyl analgesia and toxicity. European journal of pharmacology, 1991, May-17, Volume: 197, Issue:2-3 Topics: Analgesics; Animals; Brain; Drug Tolerance; Fentanyl; Lethal Dose 50; Male; Mice; Morphine; Naloxone; Naltrexone; Receptors, Opioid	1991
Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists. Brain research, 1991, Dec-20, Volume: 567, Issue:2 Topics: Animals; Depression, Chemical; Dose-Response Relationship, Drug; Female; Injections, Intraventricular; Lactation; Luteinizing Hormone; Naloxone; Naltrexone; Narcotic Antagonists; Prolactin; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa; Receptors, Opioid, mu	1991
Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions. Life sciences, 1991, Volume: 48, Issue:21 Topics: Animals; Drug Administration Schedule; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Injections, Subcutaneous; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, mu	1991
Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones. The Journal of pharmacology and experimental therapeutics, 1985, Volume: 235, Issue:3 Topics: Animals; Binding, Competitive; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Hydromorphone; In Vitro Techniques; Male; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Structure-Activity Relationship	1985
Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists. European journal of pharmacology, 1989, Oct-04, Volume: 169, Issue:1 Topics: Analgesics; Animals; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Methionine; Enkephalins; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu	1989
Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies. The Journal of pharmacology and experimental therapeutics, 1985, Volume: 235, Issue:2 Topics: Animals; Azocines; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Macaca mulatta; Morphine; Muscle Relaxation; Naloxone; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors	1985
Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1982, Volume: 2, Issue:5 Topics: Animals; Brain; Cell Membrane; Dihydromorphine; Drug Stability; Hydromorphone; Kinetics; Naloxone; Naltrexone; Oxymorphone; Receptors, Opioid; Structure-Activity Relationship	1982
Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats. Brain research, 1995, Jul-10, Volume: 685, Issue:1-2 Topics: Animals; Cerebral Ventricles; Eating; Enkephalin, Leucine-2-Alanine; Infusions, Parenteral; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sucrose	1995
Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain research, 1995, Apr-24, Volume: 678, Issue:1-2 Topics: Animals; Body Weight; Dietary Fats; Eating; Male; Naloxone; Naltrexone; Narcotic Antagonists; Obesity; Rats; Rats, Sprague-Dawley; Time Factors	1995
Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:2 Topics: Animals; Diabetes Mellitus, Experimental; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Mice; Mice, Inbred ICR; Morphine; Morphine Dependence; Motor Activity; Naloxone; Naltrexone; Receptors, Opioid, mu; Streptozocin	1995
Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats. Brain research bulletin, 1995, Volume: 36, Issue:3 Topics: Animals; Enkephalin, Leucine-2-Alanine; Hypotonic Solutions; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saline Solution, Hypertonic; Water Deprivation	1995
Unexpected prosecretory action component of loperamide at mu-opioid receptors in the guinea-pig colonic mucosa in vitro. British journal of pharmacology, 1995, Volume: 114, Issue:4 Topics: Alprostadil; Amino Acid Sequence; Animals; Chlorides; Colon; Dose-Response Relationship, Drug; Ethylketocyclazocine; Guinea Pigs; Intestinal Mucosa; Loperamide; Male; Molecular Sequence Data; Naloxone; Naltrexone; Patch-Clamp Techniques; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Theophylline	1995
Antinociceptive effect of dihydroetorphine in diabetic mice. European journal of pharmacology, 1995, Feb-24, Volume: 275, Issue:1 Topics: Analgesia; Analgesics, Opioid; Animals; Binding, Competitive; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Etorphine; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu	1995
Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1995, Volume: 15, Issue:2 Topics: Animals; Depression, Chemical; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Gastrointestinal Transit; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Naltrexone	1995
Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine. European journal of pharmacology, 1994, Aug-16, Volume: 268, Issue:3 Topics: Amino Acid Sequence; Animals; Brain Neoplasms; Cerebral Cortex; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Humans; Ligands; Molecular Sequence Data; Naloxone; Naltrexone; Neuroblastoma; Rats; Receptors, Opioid, mu; Somatostatin; Tumor Cells, Cultured	1994
Effects of diabetes on the morphine-induced Straub tail reaction in mice. Neuroscience letters, 1994, Aug-29, Volume: 178, Issue:1 Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reference Values; Tail	1994
Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats. Brain research, 1994, 09-19, Volume: 657, Issue:1-2 Topics: Animals; Drinking; Enkephalin, Leucine-2-Alanine; Injections, Intraventricular; Injections, Subcutaneous; Isoproterenol; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, mu	1994
Effect of selective mu 1, mu 2 and delta 2 opioid receptor agonists on gastric functions in the rat. Neuropharmacology, 1994, Volume: 33, Issue:8 Topics: Animals; Dose-Response Relationship, Drug; Gastric Acid; Gastric Emptying; Injections, Intraventricular; Injections, Subcutaneous; Male; Naloxone; Naltrexone; Oligopeptides; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Stomach	1994
Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1 Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Benzeneacetamides; Caudate Nucleus; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalins; Male; Molecular Sequence Data; Naloxone; Naltrexone; Nucleus Accumbens; Oligopeptides; Putamen; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Signal Transduction; Somatostatin	1993
Beta-funaltrexamine blockade of opioid-induced inhibition of somatostatin secretion from rat stomach. European journal of pharmacology, 1994, Jul-11, Volume: 259, Issue:3 Topics: Amino Acid Sequence; Analgesics; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Gastric Inhibitory Polypeptide; Gastric Mucosa; In Vitro Techniques; Male; Molecular Sequence Data; Naloxone; Naltrexone; Narcotic Antagonists; Radioimmunoassay; Rats; Rats, Wistar; Somatostatin	1994
Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors. Neuroscience letters, 1994, Jan-03, Volume: 165, Issue:1-2 Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Receptors, Opioid, mu; Spinal Cord	1994
TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis. Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:4 Topics: Animals; Corticosterone; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hypothalamo-Hypophyseal System; Kinetics; Male; Naloxone; Naltrexone; Oligopeptides; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu	1994
The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine. Brain research, 1993, Feb-19, Volume: 603, Issue:2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analysis of Variance; Animals; Blood Pressure; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Heart Rate; Hexamethonium; Hexamethonium Compounds; Indoles; Injections, Intravenous; Male; Morphinans; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pain; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reference Values; Time Factors; Vagotomy; Vagus Nerve	1993
Characterization of the mu-opioid receptors on SH-SY5Y cells using beta-funaltrexamine (beta-FNA) and naloxonazine. Biochemical Society transactions, 1993, Volume: 21, Issue:4 Topics: Analgesics; Cell Line; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Humans; Kinetics; Naloxone; Naltrexone; Narcotic Antagonists; Neuroblastoma; Receptors, Opioid, mu; Tumor Cells, Cultured	1993
Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I. European journal of pharmacology, 1993, Jan-05, Volume: 230, Issue:1 Topics: Animals; Dose-Response Relationship, Drug; Electromyography; Female; Fetus; Indoles; Injections, Intraventricular; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pregnancy; Receptors, Opioid, delta; Respiration; Sheep	1993
Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats. Physiology & behavior, 1993, Volume: 53, Issue:3 Topics: Animals; Arousal; Enkephalin, Leucine-2-Alanine; Feeding Behavior; Indoles; Male; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu	1993
Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:1 Topics: Analgesia; Animals; Brain Stem; Drug Administration Routes; Male; Mice; Morphine; Naloxone; Naltrexone; Receptors, Opioid, mu; Species Specificity; Spinal Cord	1993
Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:3 Topics: Animals; Heroin; Male; Naloxone; Naltrexone; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Self Administration	1993
CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors. Neuroendocrinology, 1993, Volume: 57, Issue:2 Topics: Animals; Corticotropin-Releasing Hormone; Female; Gonadotropin-Releasing Hormone; Hypothalamus; Kinetics; Luteinizing Hormone; Naloxone; Naltrexone; Ovariectomy; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu	1993
DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2 Topics: Analgesics; Animals; Corticosterone; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hypothalamo-Hypophyseal System; Male; Naloxone; Naltrexone; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu	1993
Role of mu 1- and delta-opioid receptors in modulation of fetal EEG and respiratory activity. The American journal of physiology, 1993, Volume: 265, Issue:2 Pt 2 Topics: Animals; Electroencephalography; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Fetal Movement; Fetus; Morphine; Naloxone; Naltrexone; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiration; Sheep	1993
Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain research, 1993, Aug-06, Volume: 618, Issue:2 Topics: Animals; Drinking Behavior; Enkephalin, Leucine-2-Alanine; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Polysaccharides; Rats; Rats, Sprague-Dawley; Saccharin	1993
Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:2 Topics: Alfentanil; Analgesia; Animals; Electromyography; Male; Muscle Rigidity; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar	1993
Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors. European journal of pharmacology, 1995, Sep-15, Volume: 284, Issue:1-2 Topics: Analgesics, Opioid; Animals; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred F344; Receptors, Opioid, mu	1995
Antinociceptive and behavioral effects of synthetic deltorphin analogs. European journal of pharmacology, 1996, Jan-18, Volume: 296, Issue:1 Topics: Analysis of Variance; Animals; Catalepsy; Dose-Response Relationship, Drug; Injections, Intraventricular; Locomotion; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu	1996
Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats. European journal of pharmacology, 1996, May-23, Volume: 304, Issue:1-3 Topics: Alcohol Drinking; Animals; Dose-Response Relationship, Drug; Drinking; Eating; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Injections, Intraperitoneal; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Receptors, Opioid, delta; Receptors, Opioid, mu	1996
Reductions in locomotor activity following central opioid receptor subtype antagonists in rats. Physiology & behavior, 1996, Volume: 60, Issue:3 Topics: Animals; Enkephalins; Locomotion; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley	1996
Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism. Pharmacology & toxicology, 1995, Volume: 77, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pain Threshold; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu	1995
Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats. Brain research, 1996, Nov-25, Volume: 741, Issue:1-2 Topics: Animals; Dose-Response Relationship, Drug; Drinking; Eating; Enkephalin, Leucine-2-Alanine; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Polysaccharides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Water Deprivation	1996
Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice. Life sciences, 1997, Volume: 60, Issue:22 Topics: Animals; Buprenorphine; Male; Mice; Mice, Inbred C57BL; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Species Specificity	1997
Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats. Pharmacology, biochemistry, and behavior, 1997, Volume: 58, Issue:1 Topics: Analgesics, Opioid; Animals; Body Temperature; Catalepsy; Conditioning, Operant; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid, mu	1997
Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes. Journal of neuroimmunology, 1997, Volume: 79, Issue:2 Topics: Animals; Avoidance Learning; Cell Division; Conditioning, Classical; Electroshock; Immune System; Killer Cells, Natural; Lipopolysaccharides; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Lew; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spleen	1997
Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors. Pharmacology & toxicology, 1998, Volume: 82, Issue:1 Topics: Analgesics, Opioid; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Morphine; Morphine Derivatives; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid	1998
Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. Life sciences, 1998, Volume: 62, Issue:16 Topics: Analgesics; Animals; Drug Synergism; Injections, Intraventricular; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Pain Measurement; Receptors, Opioid; Receptors, Opioid, mu; Secologanin Tryptamine Alkaloids	1998
Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice. Japanese journal of pharmacology, 1998, Volume: 78, Issue:4 Topics: Analgesics, Opioid; Animals; Anti-Bacterial Agents; Benzylidene Compounds; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Heroin; Injections, Intraventricular; Male; Mice; Morphine; Morphine Derivatives; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Receptors, Opioid, delta; Receptors, Opioid, mu; Streptozocin; Time Factors	1998
Dynorphin A increases substance P release from trigeminal primary afferent C-fibers. European journal of pharmacology, 1999, Jan-29, Volume: 366, Issue:1 Topics: Animals; Animals, Newborn; Capsaicin; Dizocilpine Maleate; Dynorphins; Enkephalin, Leucine; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nerve Fibers; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance P; Trigeminal Nuclei	1999
Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. European journal of pharmacology, 1999, May-07, Volume: 372, Issue:1 Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Injections, Intraventricular; Injections, Spinal; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Oligopeptides; Pain; Receptors, Opioid, mu; Time Factors	1999
Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors. European journal of pharmacology, 1999, Sep-10, Volume: 380, Issue:2-3 Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Binding, Competitive; Diarrhea; Injections, Intraventricular; Injections, Spinal; Male; Membranes; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Pyrazoles; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord; Sulfoxides	1999
The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. European journal of pharmacology, 2000, Mar-10, Volume: 391, Issue:1-2 Topics: Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Oligopeptides; Pain Measurement; Reaction Time; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu	2000
Inhibitory effect of intracerebroventricularly-administered [D-Arg(2), beta-Ala(4)]-dermorphin (1-4) on gastrointestinal transit. Peptides, 2000, Volume: 21, Issue:2 Topics: Analgesics; Animals; Charcoal; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Gastrointestinal Transit; Injections, Intraventricular; Mice; Mice, Inbred Strains; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides	2000
Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors. European journal of pharmacology, 2000, Apr-28, Volume: 395, Issue:2 Topics: Analgesics; Analgesics, Opioid; Animals; Drug Antagonism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Injections, Intraventricular; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Opioid Peptides; Pain Measurement; Receptors, Opioid, mu; Time Factors	2000
Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats. Brain research, 2000, May-12, Volume: 864, Issue:2 Topics: Animals; Antisense Elements (Genetics); Cloning, Molecular; Eating; Exons; Feeding Behavior; Injections, Intraperitoneal; Injections, Intraventricular; Locomotion; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereotyped Behavior; Thioglycolates	2000
The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection. General and comparative endocrinology, 2000, Volume: 118, Issue:3 Topics: Angiotensin II; Animals; Chickens; Male; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saline Solution, Hypertonic; Vasotocin	2000
Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test. British journal of pharmacology, 2000, Volume: 130, Issue:6 Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Interferon-alpha; Interferon-beta; Interferon-gamma; Male; Mice; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Swimming; Time Factors	2000
Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop. European journal of pharmacology, 2000, Sep-01, Volume: 403, Issue:1-2 Topics: Amino Acid Substitution; Animals; Benzamides; Benzomorphans; Binding Sites; Binding, Competitive; COS Cells; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Morphine; Mutation; Naloxone; Naltrexone; Narcotic Antagonists; Peptides; Piperazines; Protein Conformation; Radioligand Assay; Rats; Receptors, Opioid, mu; Signal Transduction; Sulfur Radioisotopes	2000
Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain research, 2000, Oct-20, Volume: 881, Issue:1 Topics: Analgesics, Opioid; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Heroin; Injections, Spinal; Male; Mice; Naloxone; Naltrexone; Oligopeptides; Pain Measurement; Receptors, Opioid, mu	2000
Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. European journal of pharmacology, 2001, Sep-21, Volume: 427, Issue:3 Topics: Analgesics; Animals; Benzylidene Compounds; Dose-Response Relationship, Drug; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Methionine; Immune Sera; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Peptide Fragments; Time Factors	2001
Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice. Neuroreport, 2001, Dec-04, Volume: 12, Issue:17 Topics: Analgesics, Opioid; Animals; Brain; Dose-Response Relationship, Drug; Drug Interactions; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Muscarinic Antagonists; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oligopeptides; Receptors, Opioid, mu; Scopolamine	2001
Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone. Peptides, 2002, Volume: 23, Issue:5 Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Injections, Spinal; Male; Mice; Naloxone; Naltrexone; Oligopeptides; Pain; Pain Measurement; Quaternary Ammonium Compounds; Reflex; Time Factors	2002
Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites. Life sciences, 2002, Apr-05, Volume: 70, Issue:20 Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, mu; Spinal Cord	2002
Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2002, Volume: 27, Issue:3 Topics: Alcohol Drinking; Analysis of Variance; Animals; Central Nervous System Depressants; Cues; Discrimination, Psychological; Ethanol; Extinction, Psychological; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Reinforcement, Psychology; Self Administration	2002
Effects of beta-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity. Pharmacology, biochemistry, and behavior, 2003, Volume: 74, Issue:3 Topics: Animals; Conditioning, Psychological; Male; Morphine; Motor Activity; Naloxone; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu	2003
Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:2 Topics: Analgesics, Opioid; Animals; Antibodies, Blocking; Cloning, Molecular; Dynorphins; Endorphins; Enkephalin, Methionine; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Injections, Intraventricular; Injections, Spinal; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pain Measurement; Radioligand Assay; Reaction Time; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu	2003
The antitussive effects of endomorphin-1 and endomorphin-2 in mice. European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3 Topics: Animals; Antitussive Agents; Capsaicin; Cough; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Oligopeptides; Receptors, Opioid, kappa; Receptors, Opioid, mu	2003
Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus. Brain research, 2003, Dec-05, Volume: 992, Issue:2 Topics: Animals; Biotin; Dextrans; Dose-Response Relationship, Drug; Electric Stimulation; Escape Reaction; Fear; Inferior Colliculi; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neural Pathways; Opioid Peptides; Periaqueductal Gray; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu	2003
Differential opioid inhibition of C- and A delta- fiber mediated thermonociception after stimulation of the nucleus raphe magnus. Anesthesia and analgesia, 2004, Volume: 98, Issue:2 Topics: Analgesics, Opioid; Animals; Electric Stimulation; Female; Hot Temperature; Injections, Spinal; Naloxone; Naltrexone; Narcotic Antagonists; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neural Pathways; Nociceptors; Raphe Nuclei; Rats; Rats, Sprague-Dawley	2004
Supraspinal anti-allodynic and rewarding effects of endomorphins in rats. Peptides, 2004, Volume: 25, Issue:4 Topics: Analgesics, Opioid; Animals; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nerve Compression Syndromes; Oligopeptides; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley	2004
A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:3 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Mice; MSH Release-Inhibiting Hormone; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, mu	2005
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse. European journal of pharmacology, 2005, Feb-10, Volume: 509, Issue:1 Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hot Temperature; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Naloxone; Naltrexone; Nociceptors; Oligopeptides; Pain; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu; Tail; Time Factors	2005
Effect of the blockade of mu1-opioid and 5HT2A-serotonergic/alpha1-noradrenergic receptors on sweet-substance-induced analgesia. Psychopharmacology, 2005, Volume: 179, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Analgesia; Animals; Dose-Response Relationship, Drug; Ketanserin; Male; Methysergide; Naloxone; Naltrexone; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Opioid, mu; Serotonin Antagonists; Sucrose; Taste	2005
The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:7 Topics: Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Depressants; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Somatostatin; Time Factors	2006
Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice. European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2 Topics: Analgesics; Animals; Avoidance Learning; Cattle; Dose-Response Relationship, Drug; Endorphins; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Memory; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Peptide Fragments; Receptors, Opioid, mu; Scopolamine	2006
The effects of endomorphins and diprotin A on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study in rats. Neurochemistry international, 2006, Volume: 49, Issue:7 Topics: Animals; Corpus Striatum; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dopamine; Electric Stimulation; Infusion Pumps; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neural Pathways; Oligopeptides; Organ Culture Techniques; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Wistar; Substantia Nigra; Synaptic Transmission	2006
Daily increase of fat ingestion mediated via mu-opioid receptor signaling pathway. Biomedical research (Tokyo, Japan), 2006, Volume: 27, Issue:6 Topics: Animals; Appetite Regulation; Corn Oil; Feeding Behavior; Male; Naloxone; Naltrexone; Narcotic Antagonists; Polysaccharides, Bacterial; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Signal Transduction	2006
Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice. European journal of pharmacology, 2007, Apr-10, Volume: 560, Issue:2-3 Topics: Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Oxycodone; Receptors, Opioid, mu; Streptozocin	2007
In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain, behavior, and immunity, 2008, Volume: 22, Issue:6 Topics: Analgesics; Animals; Benzamides; Bicuculline; Dose-Response Relationship, Drug; GABA Antagonists; Humans; Injections, Intraventricular; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Pain; Pain Measurement; Peptide Fragments; Piperidines; Receptors, Neurokinin-2; Tachykinins; Tropanes	2008
Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2. Peptides, 2008, Volume: 29, Issue:9 Topics: Analgesics; Animals; Dynorphins; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Immune Sera; Injections, Intraventricular; Male; Mice; Naloxone; Naltrexone; Oligopeptides; Protein Precursors; Receptors, Opioid, kappa; Receptors, Opioid, mu	2008
The effects of endomorphins on striatal [3H]GABA release induced by electrical stimulation: an in vitro superfusion study in rats. Neurochemical research, 2009, Volume: 34, Issue:5 Topics: Animals; Corpus Striatum; Dipeptidyl-Peptidase IV Inhibitors; Electric Stimulation; gamma-Aminobutyric Acid; Male; Naloxone; Naltrexone; Oligopeptides; Perfusion; Rats; Rats, Wistar; Receptors, Opioid, mu; Tritium	2009
Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine. Psychopharmacology, 2009, Volume: 204, Issue:3 Topics: Animals; Benzimidazoles; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Female; Heroin; Injections, Intravenous; Macaca mulatta; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Receptors, Opioid, mu; Reinforcement, Psychology; Self Administration; Substance Abuse, Intravenous	2009
Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats. Psychopharmacology, 2009, Volume: 206, Issue:1 Topics: Animals; Drug Tolerance; Ethanol; Male; Microinjections; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu	2009
Effect of opioid compounds on feeding and activity of the cockroach, Periplaneta americana. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2010, Volume: 151, Issue:3 Topics: Analgesics, Opioid; Animals; Behavior, Animal; Cockroaches; Eating; Female; Male; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Receptors, Opioid, mu; Water Loss, Insensible	2010
Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model. Peptides, 2010, Volume: 31, Issue:11 Topics: Analgesics; Animals; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pain; Peptides, Cyclic; Receptors, Opioid, mu	2010
Effect of opioid receptor blockade on acetaldehyde self-administration and ERK phosphorylation in the rat nucleus accumbens. Alcohol (Fayetteville, N.Y.), 2011, Volume: 45, Issue:8 Topics: Acetaldehyde; Animals; Enzyme Activation; Ethanol; Extracellular Signal-Regulated MAP Kinases; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Phosphorylation; Rats; Rats, Wistar; Receptors, Opioid, mu; Reinforcement, Psychology; Saccharin; Self Administration	2011
YFa and analogs: investigation of opioid receptors in smooth muscle contraction. World journal of gastroenterology, 2011, Oct-28, Volume: 17, Issue:40 Topics: Acetylcholine; Analgesics, Opioid; Animals; Cholinergic Agonists; Dynorphins; Enkephalin, Methionine; Guinea Pigs; Ileum; Male; Mice; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Naltrexone; Narcotic Antagonists; Neurotransmitter Agents; Oligopeptides; Receptors, Opioid; Vas Deferens	2011
Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system. International journal of molecular sciences, 2012, Volume: 13, Issue:9 Topics: Analgesics; Animals; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Male; Mice; Mice, Inbred ICR; Mitragyna; Naloxone; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Opioid; Secologanin Tryptamine Alkaloids	2012
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A. Neuropharmacology, 2013, Volume: 70 Topics: Analgesics; Animals; Botulinum Toxins, Type A; Dose-Response Relationship, Drug; Drug Interactions; Male; Naloxone; Naltrexone; Narcotic Antagonists; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Rats; Receptors, Opioid, mu	2013
Different types of opioid receptors involved in the suppression of LH secretion in lactating sheep. Animal reproduction science, 2013, Volume: 141, Issue:1-2 Topics: Animals; Female; Gene Expression Regulation; Guanidines; Lactation; Luteinizing Hormone; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Sheep	2013
Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA. Peptides, 2013, Volume: 50 Topics: Analgesia; Analgesics, Opioid; Animals; Endorphins; Gene Expression; Immune Sera; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naloxone; Naltrexone; Narcotic Antagonists; Nociception; Oligopeptides; Protein Precursors; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord; Tail	2013
The opioid system majorly contributes to preference for fat emulsions but not sucrose solutions in mice. Bioscience, biotechnology, and biochemistry, 2015, Volume: 79, Issue:4 Topics: Administration, Oral; Animals; Behavior, Animal; Choice Behavior; Dietary Fats; Eating; Emulsions; Food Preferences; Male; Mice; Mice, Inbred BALB C; Naloxone; Naltrexone; Narcotic Antagonists; Phospholipids; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Soybean Oil; Sucrose	2015
Prenatal exposure to vanilla or alcohol induces crawling after these odors in the neonate rat: The role of mu and kappa opioid receptor systems. Physiology & behavior, 2015, Sep-01, Volume: 148 Topics: Analysis of Variance; Animals; Animals, Newborn; Drug-Seeking Behavior; Ethanol; Female; Locomotion; Maternal Exposure; Naloxone; Naltrexone; Odorants; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Vanilla	2015
Opioid system mediated anti-nociceptive effect of agomelatine in mice. Life sciences, 2016, Oct-15, Volume: 163 Topics: Acetamides; Analgesics; Animals; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Motor Activity; Naloxone; Naltrexone; Pain; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Rotarod Performance Test	2016
Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome. Journal of psychopharmacology (Oxford, England), 2017, Volume: 31, Issue:9 Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Depression; Depressive Disorder; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Organosilicon Compounds; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Swimming	2017
The Blockade of µ1- and κ-Opioid Receptors in the Inferior Colliculus Decreases the Expression of Panic Attack-Like Behaviours Induced by Chemical Stimulation of the Dorsal Midbrain. Neuropsychobiology, 2019, Volume: 78, Issue:4 Topics: Animals; Behavior, Animal; Bicuculline; Exploratory Behavior; GABA-A Receptor Antagonists; Inferior Colliculi; Male; Mesencephalon; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Panic; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu	2019